REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism

Clinical trial NCT06689254 · RECRUITING

Trial details

NCT number: NCT06689254
Sponsor: Christiaan Vinkers
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment-resistant PTSD

Start date: 2024-11-15
Primary completion: 2026-09-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.